Trial Details
COMPLETEDBasic Information
| Clinical ID | c4323 |
|---|---|
| Identifier | NCT00705484 |
| Trial Title | European Safety Registry in Ulcerative Colitis (P04808) |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Ulcerative Colitis |
| Interventions | BIOLOGICAL: infliximab|DRUG: Standard Therapy |
Participant Information
| Sponsor | Merck Sharp & Dohme LLC |
|---|---|
| City | - |
| Country/Region | - |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | OBSERVATIONAL |
|---|---|
| Phase | NULL |
Time Information
| Start Date | 2007-06-01 |
|---|---|
| Primary Completion Date | 2016-10-20 |
| Completion Date | 2016-10-20 |